Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-2.440%
-0.15
-2.440%
-
 
08:37 / Frankfurt WKN: A1XE7A / Name: Knight / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Knight Therapeutics Stock

We can see a decrease in the price for Knight Therapeutics. Compared to yesterday it has lost -€0.150 (-2.440%).

Pros and Cons of Knight Therapeutics in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Knight Therapeutics vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Knight Therapeutics -2.440% 1.653% 7.895% 64.439% 65.323% 87.500% 80.882%
Biomark Diagnostics Inc. -0.630% 1.274% 0.000% 67.368% 15.217% 122.378% 127.143%
MicroPlanet Technology Corp 6.200% -0.769% -11.034% -13.423% -15.132% -23.669% -20.859%
Avricore Health Inc. 26.000% 0.000% 12.500% -29.213% 36.957% -69.712% -69.417%

News

Knight-Swift Transportation Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Knight-Swift Transportation Q2 Earnings Call Highlights

Key Points

Why Shares in Knight-Swift Transportation Crashed This Week: https://g.foolcdn.com/editorial/images/875348/gettyimages-1224645289-1200x800-5b2df79.jpg
Why Shares in Knight-Swift Transportation Crashed This Week

Knight-Swift Transportation (NYSE: KNX) is the largest full truckload carrier in the U.S., and it's always going to be at the center of the never-ending debate over where trucking companies are in

Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch NearsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears

Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief